Valuation : Lead Data Inc.

Market Cap 539M 17.09M 14.69M 13.82M 12.62M 23.54M 1.62B 23.67M 164M 63.37M 828M 64.18M 62.78M 2.64B P/E 2024
-3.97x
P/E 2025 -12.2x
Enterprise Value 568M 18.01M 15.49M 14.57M 13.3M 24.82M 1.71B 24.95M 173M 66.8M 873M 67.65M 66.17M 2.78B EV / Sales 2024
33.7x
EV / Sales 2025 5.13x
Free-Float
64.34%
Yield 2024 *
-
Yield 2025 -
3 years 2.27
Extreme 2.27
6.48
5 years 2.27
Extreme 2.27
6.48
10 years 1.89
Extreme 1.89
8.54
Manager TitleAgeSince
Chief Executive Officer - 2022-08-16
Director of Finance/CFO - 2022-06-09
Corporate Officer/Principal - 2022-06-09
Director TitleAgeSince
Director/Board Member - 2019-06-09
Chairman - 2022-08-16
Director/Board Member - 2022-06-09
Change 5-day change 1-year change 3-year change Capi.($)
-9.85%-.--%-.--%+13.33% 17.09M
-0.48%-2.06%+30.86%+19.18% 9.9B
-0.08%+0.29%+4.98%+0.19% 1.4B
+0.85%-1.21% - - 1.33B
-1.48%-2.31%-5.74%-15.83% 1.14B
-0.22%+7.92%+98.66%+61.43% 794M
+1.61%-0.34%-22.43%-53.21% 614M
-0.14%-0.14%-15.67%-11.65% 425M
0.00%-3.03%+94.21%+144.13% 419M
-0.24%-0.24%-6.51%+13.12% 223M
Average -1.00%-1.96%+19.82%+18.97% 1.63B
Weighted average by Cap. -0.28%+0.32%+26.91%+16.53%

Financials

2024 2025
Net sales 15.47M 491K 422K 397K 362K 676K 46.51M 679K 4.7M 1.82M 23.77M 1.84M 1.8M 75.66M 111M 3.51M 3.02M 2.84M 2.59M 4.84M 333M 4.86M 33.65M 13.02M 170M 13.19M 12.9M 541M
Net income -134M -4.24M -3.65M -3.43M -3.13M -5.85M -402M -5.88M -40.68M -15.74M -206M -15.94M -15.59M -654M -44.02M -1.4M -1.2M -1.13M -1.03M -1.92M -132M -1.93M -13.38M -5.18M -67.67M -5.24M -5.13M -215M
Net Debt -16.95M -538K -462K -435K -397K -741K -50.99M -745K -5.15M -1.99M -26.06M -2.02M -1.98M -82.93M 29.12M 924K 794K 747K 682K 1.27M 87.58M 1.28M 8.85M 3.43M 44.76M 3.47M 3.39M 142M
Logo Lead Data Inc.
Lead Data Inc is a Taiwan-based company principally engaged in the trading business of medical equipment. The Company’s main products include continuous positive airway pressures (CPAP), hearing aids, oxygen concentrators, oxygen concentrators and rapid screening reagents for novel coronavirus pneumonia (COVID-19). CPAP can treat obstructive sleep apnea. It also has great benefits in improving sleep quality and solving snoring problems. The Company mainly operates in Taiwan and mainland China.
Employees
-
  1. Stock Market
  2. Stocks
  3. 2443 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!